Matthew C. Busch - 19 Feb 2026 Form 4 Insider Report for AMGEN INC (AMGN)

Role: VP, Finance & CAO
Signature: /s/ Matthew C. Busch
Issuer symbol: AMGN
Transactions as of: 19 Feb 2026
Net transactions value: -$375,790
Form type: 4
Filing time: 20 Feb 2026, 19:43:21 UTC
Previous filing: 07 Nov 2025
Next filing: 05 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Busch Matthew C.	VP, Finance & CAO	ONE AMGEN CENTER DRIVE, THOUSAND OAKS	/s/ Matthew C. Busch	20 Feb 2026	0001987926

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMGN	Common Stock	Sale	$375,790	-1,000	-23%	$375.79	3,423	19 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares include 60 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Content

These shares include 60 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.